Cephalon, Inc. (CEPH) - NASDAQ
CEPH is defunct.
Company Description
Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system ("CNS"), pain, oncology and inflammatory disease. In addition to conducting an active... More
Sector: Healthcare
Industry: Biotechnology
Country: United States